Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells

Eun-Bin Kim,Hye-Yoon Jeon,Yung-Taek Ouh,Ah-Jun Lee,Chan-Hee Moon,Sung Hun Na,Kwon-Soo Ha
DOI: https://doi.org/10.1016/j.biopha.2024.116232
IF: 7.419
2024-02-04
Biomedicine & Pharmacotherapy
Abstract:Proinsulin C-peptide, a biologically active polypeptide released from pancreatic β-cells, is known to prevent hyperglycemia-induced microvascular leakage; however, the role of C-peptide in migration and invasion of cancer cells is unknown. Here, we investigated high glucose-induced migration and invasion of ovarian cancer cells and the inhibitory effects of human C-peptide on metastatic cellular responses. In SKOV3 human ovarian cancer cells, high glucose conditions activated a vicious cycle of reactive oxygen species (ROS) generation and transglutaminase 2 (TGase2) activation through elevation of intracellular Ca 2+ levels. TGase2 played a critical role in high glucose-induced ovarian cancer cell migration and invasion through β-catenin disassembly. Human C-peptide inhibited high glucose-induced disassembly of adherens junctions and ovarian cancer cell migration and invasion through inhibition of ROS generation and TGase2 activation. The preventive effect of C-peptide on high glucose-induced ovarian cancer cell migration and invasion was further demonstrated in ID8 murine ovarian cancer cells. Our findings suggest that high glucose conditions induce the migration and invasion of ovarian cancer cells, and human C-peptide inhibits these metastatic responses by preventing ROS generation, TGase2 activation, and subsequent disassembly of adherens junctions.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?